Robert D. Bigler

1.7k total citations · 1 hit paper
31 papers, 1.4k citations indexed

About

Robert D. Bigler is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert D. Bigler has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert D. Bigler's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Cutaneous lymphoproliferative disorders research (8 papers) and T-cell and Retrovirus Studies (6 papers). Robert D. Bigler is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Cutaneous lymphoproliferative disorders research (8 papers) and T-cell and Retrovirus Studies (6 papers). Robert D. Bigler collaborates with scholars based in United States, Switzerland and Italy. Robert D. Bigler's co-authors include David N. Posnett, J W Kappler, Yongwon Choi, Brian L. Kotzin, S Carrel, Arthur W. Boylston, Philippa Marrack, Erwin W. Gelfand, Eric C. Vonderheid and Nicholas Chiorazzi and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Robert D. Bigler

31 papers receiving 1.4k citations

Hit Papers

Vβ-Specific Stimulation of Human T Cells by Staphylococca... 1989 2026 2001 2013 1989 200 400 600

Peers

Robert D. Bigler
C K Goldman United States
Géraldine Grouard Switzerland
Yueh-hsiu Chien United States
Antje Necker Germany
Jean Nichols United States
David Stephany United States
Linda Hibbert United Kingdom
W.P. Zeijlemaker Netherlands
Yasmine M. Hijazi United States
C K Goldman United States
Robert D. Bigler
Citations per year, relative to Robert D. Bigler Robert D. Bigler (= 1×) peers C K Goldman

Countries citing papers authored by Robert D. Bigler

Since Specialization
Citations

This map shows the geographic impact of Robert D. Bigler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Bigler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Bigler more than expected).

Fields of papers citing papers by Robert D. Bigler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Bigler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Bigler. The network helps show where Robert D. Bigler may publish in the future.

Co-authorship network of co-authors of Robert D. Bigler

This figure shows the co-authorship network connecting the top 25 collaborators of Robert D. Bigler. A scholar is included among the top collaborators of Robert D. Bigler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert D. Bigler. Robert D. Bigler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vonderheid, Eric C., et al.. (2005). Evidence for Restricted Vβ Usage in the Leukemic Phase of Cutaneous T Cell Lymphoma. Journal of Investigative Dermatology. 124(3). 651–661. 34 indexed citations
2.
Vonderheid, Eric C., Stuart R. Lessin, Marcia Polansky, et al.. (1998). Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma. Journal of the American Academy of Dermatology. 38(2). 207–220. 66 indexed citations
3.
Marks, David I., Eric C. Vonderheid, Robert D. Bigler, et al.. (1996). Analysis of p53 and mdm‐2 expression in 18 patients with Sézary syndrome. British Journal of Haematology. 92(4). 890–899. 29 indexed citations
4.
Bigler, Robert D., et al.. (1996). Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome.. PubMed. 149(5). 1477–83. 15 indexed citations
5.
Vonderheid, Eric C., et al.. (1994). Extracorporeal Photopheresis and Recombinant Interferon Alfa 2b in Sezary Syndrome. American Journal of Clinical Oncology. 17(3). 255–263. 40 indexed citations
6.
Esfahani, Mojtaba, et al.. (1993). Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1149(2). 217–223. 36 indexed citations
7.
Esfahani, Mojtaba, et al.. (1993). Effect of lovastatin on cell surface expression of Fc receptors or CD14 antigen in human monocytes. Biochemical Pharmacology. 46(12). 2333–2336. 1 indexed citations
8.
Esfahani, Maryam, et al.. (1993). Lipoproteins Upregulate High Affinity FC Receptors in Human Monocytes. Biochemical and Biophysical Research Communications. 191(2). 610–616. 4 indexed citations
9.
Akolkar, Pradip N., Beena Gulwani-Akolkar, Robert G. Pergolizzi, Robert D. Bigler, & Jack Silver. (1993). Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. The Journal of Immunology. 150(7). 2761–2773. 115 indexed citations
10.
Hubbell, Howard R., Hugo E. Vargas, Edward Pequignot, et al.. (1992). Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft. Cancer Immunology Immunotherapy. 35(3). 151–157. 4 indexed citations
11.
Hubbell, Howard R., et al.. (1992). Potentiated lymphokine-activated killer cell activity generated by low-dose interleukin-2 and mismatched double-stranded RNA. Cancer Immunology Immunotherapy. 34(4). 259–264. 1 indexed citations
12.
Vonderheid, Eric C., Chan Kang, Marshall E. Kadin, et al.. (1990). Extracorporeal photopheresis in psoriasis vulgaris: Clinical and immunologic observations. Journal of the American Academy of Dermatology. 23(4). 703–712. 25 indexed citations
13.
Bigler, Robert D., et al.. (1990). Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.. Proceedings of the National Academy of Sciences. 87(13). 4981–4985. 25 indexed citations
14.
Bigler, Robert D., et al.. (1989). Effect of low-density lipoprotein on the expression of high affinity Fcγ receptors. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1011(2-3). 102–109. 7 indexed citations
15.
Kappler, J W, Brian L. Kotzin, Erwin W. Gelfand, et al.. (1989). Vβ-Specific Stimulation of Human T Cells by Staphylococcal Toxins. Science. 244(4906). 811–813. 611 indexed citations breakdown →
16.
Bigler, Robert D., Yuri Bushkin, & Nicholas Chiorazzi. (1988). S152 (CD27). A modulating disulfide-linked T cell activation antigen.. The Journal of Immunology. 141(1). 21–28. 42 indexed citations
17.
Bigler, Robert D.. (1987). A comparison of low‐power helium‐cadmium and argon ultraviolet lasers in commercial flow cytometers. Cytometry. 8(5). 441–444. 9 indexed citations
18.
Bigler, Robert D., et al.. (1985). Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor.. The Journal of Experimental Medicine. 161(6). 1450–1463. 34 indexed citations
19.
Posnett, David N., Robert D. Bigler, Yuri Bushkin, et al.. (1984). T cell antiidiotypic antibodies reveal differences between two human leukemias.. The Journal of Experimental Medicine. 160(2). 494–505. 26 indexed citations
20.
Bigler, Robert D., et al.. (1983). Idiotype-like molecules on cells of a human T cell leukemia.. The Journal of Experimental Medicine. 158(3). 1000–1005. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026